Blood test could cut unneeded drug use in critically ill
NCT ID NCT02154178
Summary
This study tested whether using specific blood tests (fungal biomarkers) could help doctors safely stop antifungal medication sooner in critically ill ICU patients who started the drugs as a precaution. It involved 110 adult ICU patients who were started on antifungal treatment without a confirmed infection. The goal was to see if the biomarker results could guide doctors to discontinue treatment early, reducing unnecessary drug exposure and its associated costs and risks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICU, Salengro Hospital, University Hospital of Lille
Lille, Nord, 59035, France
Conditions
Explore the condition pages connected to this study.